IMAGE: Giorgio Trinchieri, M.D., NIH, National Cancer Institute, Center for Cancer Research is the recipient of the 2018 ICIS-BioLegend William E Paul Award for Excellence in Cytokine Research in recognition of… view more
Credit: International Cytokine & Interferon Society
Giorgio Trinchieri, MD, NIH, National Cancer Institute, Center for Cancer Research is the recipient of the 2018 ICIS-BioLegend William E Paul Award for Excellence in Cytokine Research in recognition of his collective contributions to the field of cytokine biology. “The ICIS is honored to present the BioLegend William E. Paul Award to Dr. Trinchieri this year for his pioneering contributions to our understanding of the role of cytokines in inflammation, immunity, and cancer. His discovery of interleukin-12 provided the link between cells and cytokines of innate immunity with those of adaptive immunity. His cutting-edge research on the interface of inflammation and immunity will continue to provide knowledge that will translate basic science discoveries to clinical therapeutics.” said Dr. Nancy Reich Marshall, President of the ICIS.
Dr. Trinchieri is currently the Director of the Cancer and Inflammation Program, an NIH Distinguished Investigator and Head of the Cancer Immunobiology Section. Previously Dr. Trinchieri held positions as Professor and Chair of the Immunology
Article originally posted at